Pulmonary tuberculosis and Eosinophil count increased

Summary:

Eosinophil count increased is found among people with Pulmonary tuberculosis, especially for people who are female, 50-59 old.

The study analyzes which people have Eosinophil count increased with Pulmonary tuberculosis. It is created by eHealthMe based on reports of 14 people who have Pulmonary tuberculosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary tuberculosis?

Pulmonary tuberculosis (lungs tuberculosis) is found to be associated with 340 drugs and 1,026 conditions by eHealthMe. Check the latest studies of Pulmonary tuberculosis.

What is Eosinophil count increased?

Eosinophil count increased is found to be associated with 768 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Eosinophil count increased.



On Jul, 27, 2026

14 people who have Pulmonary Tuberculosis and Eosinophil Count Increased are studied.

Would you have Eosinophil count increased when you have Pulmonary tuberculosis?

Gender of people who have Pulmonary Tuberculosis and experienced Eosinophil Count Increased *:

  • female: 54.55 %
  • male: 45.45 %

Age of people who have Pulmonary Tuberculosis and experienced Eosinophil Count Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 27.27 %
  • 30-39: 9.09 %
  • 40-49: 0.0 %
  • 50-59: 45.45 %
  • 60+: 18.18 %

Common co-existing conditions for these people *:

  1. Ill-Defined Disorder: 3 people, 21.43%
  2. White Blood Cell Count Abnormal: 2 people, 14.29%
  3. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 14.29%
  4. Mycobacterial Infection: 2 people, 14.29%
  5. Lymph Node Tuberculosis: 2 people, 14.29%
  6. Hiv Infection: 2 people, 14.29%
  7. Drug Hypersensitivity: 2 people, 14.29%
  8. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 14.29%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%

Common drugs taken by these people *:

  1. Pyrazinamide: 5 people, 35.71%
  2. Levofloxacin: 4 people, 28.57%
  3. Rifampin: 4 people, 28.57%
  4. Ethambutol Hydrochloride: 4 people, 28.57%
  5. Isoniazid: 4 people, 28.57%
  6. Streptomycin Sulfate: 4 people, 28.57%
  7. Clarithromycin: 3 people, 21.43%
  8. Acetaminophen: 3 people, 21.43%
  9. Dovato: 2 people, 14.29%
  10. Dolutegravir: 2 people, 14.29%

Common symptoms for these people *:

  1. Fever: 9 people, 64.29%
  2. Drug Hypersensitivity: 7 people, 50.00%
  3. Rashes (redness): 7 people, 50.00%
  4. Alanine Aminotransferase Increased: 6 people, 42.86%
  5. Aspartate Aminotransferase Increased: 6 people, 42.86%
  6. White Blood Cell Count Increased: 4 people, 28.57%
  7. Skin Blushing/flushing (a sudden reddening of the face, neck): 4 people, 28.57%
  8. Face Oedema (swelling of face): 4 people, 28.57%
  9. Itching: 4 people, 28.57%
  10. Skin Exfoliation (removal of the oldest dead skin cells): 4 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eosinophil count increased?

- Check whether Eosinophil count increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Eosinophil count increased:

All the conditions that are associated with Eosinophil count increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eosinophil count increased and Pulmonary tuberculosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: